Next report date
Report period
H1 2024
EPS estimate
—
Revenue estimate
—
−0.0065EUR
−14.88 MEUR
276.29 MEUR
1.32 B
About VIVA BIOTECH HOLDINGS
Sector
Industry
CEO
Chen Mao
Website
Headquarters
Shanghai
Employees (FY)
2.08 K
Founded
2008
FIGI
BBG00QJ361R7
Viva Biotech Holdings engages in the discovery, development, and manufacturing of clinical drugs. It operates through Drug Discovery, and Contract Development Manufacture Organisation (“CDMO”) and Commercialization segments. The Drug Discovery segment involves in structure-based drug discovery services to biotechnology and pharmaceutical customers for their pre-clinical stage innovative drug development. The Contract Development Manufacture Organisation (“CDMO”) and Commercialization segment consists of contract development and manufacturing services for small molecule APIs and intermediates and trading of APIs, intermediates and formulations. The company was founded by Feng Mao Hua, Chen Cheney Mao and Ying Wu on August 27, 2008 and is headquartered in Shanghai, China.
Viva Biotech (1873.HK) Good Sign to buy!?Share price of Viva Biotech (1873.HK) was up by 19.6% to $10.44 today (5th Aug 2020).
The share price has been passed over the last highest price ($10.16) one month ago on 7th Jul 2020.
Pivot point was existed and come together with a high volume and was ended up to the highest price.
Therefore, it
See all ideas
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
Depending on the exchange, the stock ticker may vary. For instance, on FWB exchange VIVA BIOTECH HOLD stocks are traded under the ticker VB0.
VIVA BIOTECH HOLD is going to release the next earnings report on Aug 26, 2024. Keep track of upcoming events with our Earnings Calendar.
Yes, you can track VIVA BIOTECH HOLD financials in yearly and quarterly reports right on TradingView.
VB0 net income for the last quarter is −14.68 M EUR, while the quarter before that showed 133.99 K EUR of net income which accounts for −11.05 K% change. Track more VIVA BIOTECH HOLD financial stats to get the full picture.
Like other stocks, VB0 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade VIVA BIOTECH HOLD stock right from TradingView charts — choose your broker and connect to your account.
As of Apr 28, 2024, the company has 2.08 K employees. See our rating of the largest employees — is VIVA BIOTECH HOLD on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. VIVA BIOTECH HOLD EBITDA is 51.40 M EUR, and current EBITDA margin is 18.53%. See more stats in VIVA BIOTECH HOLD financial statements.